Search for: "CIPLA LIMITED" Results 1 - 20 of 51
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 May 2021, 6:25 am by Badrinath Srinivasan
Murali Neelakantan - Principal Lawyer, Amicus and former Global General Counsel, Cipla Limited The panellists for Session I are: 1. [read post]
21 Mar 2017, 11:45 pm
Kat konfusion regarding passing off: likelihood of confusion and the Starbucks (HK) caseIPKat Neil Wilkof muses about the complexity of the three requirements of passing off and the issue of likelihood of confusion as they played out in the UKSC’s Starbucks (HK) decision.Thursday ThingiesThis Kitten reports forthcoming events in Bournemouth (3D Printing), Budapest, Minnesota, Basel and Geneva.Wednesday WhimsiesInternKat Hayleigh Bosher summarizes IP news and events including an IP Ball.First… [read post]
14 Mar 2017, 1:59 am
The plaintiff, Cipla Limited (CL) is a well-known Indian pharma company, while the defendant, Cipla Industries Pvt Ltd (CIPL), runs a business in varied household goods. [read post]
31 Oct 2016, 11:33 am
This federal lawsuit, commenced in the Southern District of Indiana, lists two Defendants, Cipla Limited of Mumbai, India and its wholly owned subsidiary Cipla USA, Inc. of Miami, Florida. [read post]
11 Mar 2015, 9:15 am by Thomas Valenti
They do not like change and hesitate to expose their clients to the uncertain risks of an ADR process of which they have limited awareness. [read post]
13 Feb 2014, 9:04 am
Indianapolis, Indiana - Indiana patent lawyers for Alcon Research, LTD of Fort Worth, Texas and Alcon Pharmaceuticals Ltd of Fribourg, Switzerland (collectively, "Alcon") sued in the Southern District of Indiana alleging that Cipla Limited of Mumbai Central, Mumbai and Cipla USA Inc. of Miami, Florida (collectively, "Cipla") infringed Olopatadine Formulations for Topical Administration, Patent Nos. 6,995,186 (the "'186 patent") and 7,402,609 (the "'609 patent"),… [read post]
18 Feb 2013, 12:46 am by Anubha Sinha
Yusuf Hamied is the Chairman of Cipla and, is also known as the Grand Old Man of the Indian Pharmaceuticals Industry. [read post]
11 Feb 2013, 7:40 pm by Sai Vinod
Cipla for one continues to manufacture generic equivalents of Sorafenib despite a valid patent held by Bayer. [read post]
15 Jan 2013, 11:49 am by Prashant Reddy
Cipla has always been appealing to the Indian government to modify its intellectual property laws to safeguard Indian consumers from monopoly. [read post]
31 Dec 2012, 1:52 pm by Swaraj Paul Barooah
Cipla patent infringement suit was India’s first pharmaceutical patent litigation in the Post TRIPS era. [read post]
2 Nov 2012, 2:38 am by Shamnad Basheer
However, this issue should not concern the IPAB which is limited to examining the technological proficiency of the invention: whether or not it is patentable.Pegasus offers considerable scope for the IPAB to place our patent jurisprudence on firmer legal moorings and resuscitate it from a more fanciful past." [read post]
5 Aug 2012, 7:34 am by Prashant Reddy
It should be remembered that companies like Cipla derive almost 40% to 50% of their annual revenues from American and European markets. [read post]
4 Jun 2012, 3:00 am by Louis M. Solomon
  The contempt citation read on Cipla, which the defendants said limited its activities of a joint venture in India. [read post]
14 Mar 2012, 6:40 am
The patentee is Bayer Corporation, and the applicant for an compulsory license is Natco Pharma Limited, an Indian generic pharmaceuticals company. [read post]
15 Jul 2011, 7:40 am by Mark Zamora
It is also manufactured and marketed by Cipla under trade name Tiova. [read post]